As part of President Obama’s Precision Medicine Initiative, the U.S. Food and Drug Administration is developing a new approach for evaluating next generation sequencing technologies—tests that rapidly sequence large segments of a person’s DNA, or even their entire genome.

Next generation sequencing involves a single test that can potentially identify thousands—even millions—of genetic variants carried by a single individual helping to diagnose or predict a person’s risk of diseases, and assisting physicians in determining the best course of treatment.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access